Aurinia Pharmaceuticals Inc
AUPHHealthcare|Biotechnology|Canada
$15.79
-0.81 (-4.88%)
DCF (FCF)
$1.77
Tangible Book
$4.31
Graham Number
$14.51
Ownership Breakdown
—
Institutional
—
Insider
—
Float
—
Shares Outstanding
Insider Trades (78)
| Insider | Position | Date | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| TANG KEVIN | CEO, 10% Owner | 2026-06-02 | BUY | 814,606 | $15.29 | $12455.3K |
| TANG KEVIN | Director | 2026-03-03 | BUY | 900,000 | $14.1 | $12690K |
| TANG KEVIN | Director | 2025-08-05 | BUY | 1,300,000 | $10.45 | $13585K |
| Keenan Greg | Chief Medical Officer | 2025-08-01 | SELL | 20,000 | $10.5 | $210K |
| Keenan Greg | Chief Medical Officer | 2025-03-07 | SELL | 8,305 | $8.23 | $68.4K |
| Miller Joseph M | CFO | 2025-03-04 | SELL | 118,013 | $7.96 | $939.4K |
| TANG KEVIN | Director | 2025-03-04 | BUY | 1,600,000 | $7.95 | $12720K |
| Donley Matthew Maxwell | COO | 2025-03-04 | SELL | 124,893 | $7.96 | $994.1K |
| Robertson Stephen P. | EVP, General Counsel | 2025-03-04 | SELL | 122,479 | $7.96 | $974.9K |
| Greenleaf Peter | CEO | 2025-03-04 | SELL | 360,540 | $7.96 | $2869.9K |
| Keenan Greg | Chief Medical Officer | 2025-03-03 | SELL | 12,239 | $8 | $97.9K |
| TANG KEVIN | Director | 2024-12-09 | BUY | 1,200,000 | $9.02 | $10824K |
| Bailey Jeffrey Allen | Director | 2024-11-11 | SELL | 4,557 | $8.43 | $38.4K |
| Smith Karen L. | Director | 2024-11-11 | SELL | 5,241 | $8.43 | $44.2K |
| Habig Scott Michael | Chief Commercial Officer | 2024-08-06 | SELL | 18,249 | $5.31 | $96.9K |
| Balakrishnan Brinda | Director | 2024-05-21 | SELL | 520 | $5.74 | $3K |
| Billen Daniel | Director | 2024-05-21 | SELL | 5,252 | $5.74 | $30.1K |
| Jayne David R.W. | Director | 2024-05-21 | SELL | 4,946 | $5.74 | $28.4K |
| Leversage Jill | Director | 2024-05-21 | SELL | 5,610 | $5.74 | $32.2K |
| MacKay-Dunn R. Hector | Director | 2024-05-21 | SELL | 5,630 | $5.74 | $32.3K |
| Greenleaf Peter | CEO | 2024-03-06 | SELL | 126,981 | $5.6 | $711.1K |
| Miller Joseph M | CFO | 2024-03-06 | SELL | 34,811 | $5.6 | $194.9K |
| Donley Matthew Maxwell | EVP, Ops & Strategy | 2024-03-06 | SELL | 40,665 | $5.51 | $224.1K |
| Habig Scott Michael | Chief Commercial Officer | 2024-03-06 | SELL | 17,777 | $5.6 | $99.6K |
| Robertson Stephen P. | EVP, General Counsel | 2024-03-06 | SELL | 57,745 | $5.6 | $323.4K |
| Knappertz Volker | EVP, Research and Development | 2024-02-27 | SELL | 4,930 | $6.1 | $30.1K |
| Knappertz Volker | EVP, Research and Development | 2024-02-20 | SELL | 25,146 | $5.48 | $137.8K |
| Habig Scott Michael | Chief Commercial Officer | 2024-02-20 | SELL | 15,867 | $5.48 | $87K |
| Jayne David R.W. | Director | 2023-05-23 | SELL | 8,733 | $11.26 | $98.3K |
| Billen Daniel | Director | 2023-05-23 | SELL | 4,650 | $11.26 | $52.4K |
| MacKay-Dunn R. Hector | Director | 2023-05-23 | SELL | 4,818 | $11.26 | $54.3K |
| Leversage Jill | Director | 2023-05-23 | SELL | 4,815 | $11.26 | $54.2K |
| Hagan Joseph P | Director | 2023-05-19 | SELL | 272 | $10.58 | $2.9K |
| MILNE GEORGE M JR | Director | 2023-03-02 | BUY | 20,000 | $8.91 | $178.2K |
| Miller Joseph M | CFO | 2023-03-02 | SELL | 11,296 | $8.94 | $101K |
| Robertson Stephen P. | EVP, General Counsel | 2023-03-02 | SELL | 19,402 | $8.94 | $173.5K |
| Greenleaf Peter | CEO | 2023-03-02 | SELL | 32,750 | $8.94 | $292.8K |
| Greenleaf Peter | CEO | 2023-03-02 | SELL | 33,047 | $8.78 | $290.2K |
| Robertson Stephen P. | EVP, General Counsel | 2023-03-02 | SELL | 19,644 | $8.78 | $172.5K |
| Miller Joseph M | CFO | 2023-03-02 | SELL | 11,398 | $8.78 | $100.1K |
| Donley Matthew Maxwell | Ex VP, Internal Operations | 2022-11-21 | BUY | 10,000 | $4.66 | $46.6K |
| Habig Scott Michael | Chief Commercial Officer | 2022-11-09 | BUY | 5,000 | $5.02 | $25.1K |
| Martin Michael Robert | Chief Business Officer | 2022-11-07 | BUY | 30,000 | $5.16 | $154.8K |
| MacKay-Dunn R. Hector | Director | 2022-03-09 | BUY | 5,000 | $11 | $55K |
| Greenleaf Peter | CEO | 2022-03-02 | SELL | 9,068 | $12.01 | $108.9K |
| Solomons Neil | Chief Medical Officer | 2022-03-02 | SELL | 4,846 | $12.01 | $58.2K |
| Huizinga Robert Bindert | EVP of Research | 2022-03-02 | SELL | 4,849 | $12.01 | $58.2K |
| Martin Michael Robert | Chief Business Officer | 2022-03-02 | SELL | 4,849 | $12.01 | $58.2K |
| Donley Matthew Maxwell | Ex VP, Intern'l Operations | 2022-03-02 | SELL | 3,052 | $12.01 | $36.7K |
| Miller Joseph M | CFO | 2022-03-02 | SELL | 3,060 | $12.01 | $36.8K |
| Colao Massimilano | Chief Commercial Officer | 2022-03-02 | SELL | 3,205 | $12.01 | $38.5K |
| Leversage Jill | Director | 2021-12-13 | BUY | 1,600 | $20.04 | $32.1K |
| Solomons Neil | Chief Medical Officer | 2021-11-11 | SELL | 250,000 | $30.03 | $7507.5K |
| Martin Michael Robert | Chief Business Officer | 2021-11-11 | SELL | 150,000 | $30.25 | $4537.5K |
| Solomons Neil | Chief Medical Officer | 2021-11-01 | SELL | 45,000 | $31.64 | $1423.8K |
| Martin Michael Robert | Chief Business Officer | 2021-11-01 | SELL | 45,000 | $31.64 | $1423.8K |
| Huizinga Robert Bindert | EVP of Research | 2021-10-25 | SELL | 130,000 | $29.75 | $3867.5K |
| Martin Michael Robert | Chief Business Officer | 2021-09-21 | SELL | 116,000 | $23.44 | $2719K |
| Huizinga Robert Bindert | EVP of Research | 2021-09-21 | SELL | 32,500 | $23.99 | $779.7K |
| Huizinga Robert Bindert | EVP of Research | 2021-09-14 | SELL | 32,500 | $21.15 | $687.4K |
| Martin Michael Robert | Chief Business Officer | 2021-09-14 | SELL | 44,000 | $21.78 | $958.3K |
| Martin Michael Robert | Chief Business Officer | 2021-09-14 | SELL | 115,000 | $20.89 | $2402.4K |
| Solomons Neil | Chief Medical Officer | 2021-09-10 | SELL | 150,000 | $19.84 | $2976K |
| Martin Michael Robert | Chief Business Officer | 2021-09-07 | SELL | 7,500 | $18.1 | $135.8K |
| Huizinga Robert Bindert | EVP of Research | 2021-09-07 | SELL | 5,000 | $18.3 | $91.5K |
| Martin Michael Robert | Chief Business Officer | 2021-08-26 | SELL | 22,500 | $17.81 | $400.7K |
| Solomons Neil | Chief Medical Officer | 2021-08-25 | SELL | 5,000 | $15.85 | $79.3K |
| Solomons Neil | Chief Medical Officer | 2021-08-09 | SELL | 45,000 | $16.03 | $721.4K |
| Martin Michael Robert | Chief Business Officer | 2021-08-09 | SELL | 5,000 | $16.01 | $80.1K |
| Martin Michael Robert | Chief Business Officer | 2021-07-28 | SELL | 5,000 | $13.86 | $69.3K |
| Martin Michael Robert | Chief Business Officer | 2021-06-22 | SELL | 5,000 | $13.76 | $68.8K |
| Miller Joseph M | CFO | 2021-05-11 | BUY | 1,000 | $9.74 | $9.7K |
| Leversage Jill | Director | 2021-05-11 | BUY | 2,500 | $10.96 | $27.4K |
| Greenleaf Peter | CEO | 2021-05-11 | BUY | 5,125 | $10.71 | $54.9K |
| Solomons Neil | Chief Medical Officer | 2021-03-12 | SELL | 40,000 | $13.49 | $539.6K |
| MILNE GEORGE M JR | Director | 2021-03-05 | BUY | 5,000 | $13 | $65K |
| Leversage Jill | Director | 2021-01-29 | BUY | 1,600 | $16.03 | $25.6K |
| Robertson Stephen P. | EVP, General Counsel | 2021-01-28 | BUY | 900 | $16.14 | $14.5K |
Congress & Senate Trades
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Guru Activity
1 gurus tracked